Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial

dc.contributor.author	Backert, Linus
dc.date.accessioned	2019-04-25T14:43:19Z
dc.date.available	2019-04-25T14:43:19Z
dc.date.issued	2017
dc.identifier.issn	1474-547X
dc.identifier.uri	http://hdl.handle.net/10900/88082
dc.language.iso	en	en
dc.publisher	Elsevier Science Inc	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/S0140-6736(17)31665-3
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190131163842_01113
utue.publikation.seiten	1511-1520	de_DE
utue.personen.roh	Alberer, Martin
utue.personen.roh	Gnad-Vogt, Ulrike
utue.personen.roh	Hong, Henoch Sangjoon
utue.personen.roh	Mehr, Keyvan Tadjalli
utue.personen.roh	Backert, Linus
utue.personen.roh	Finak, Greg
utue.personen.roh	Gottardo, Raphael
utue.personen.roh	Bica, Mihai Alexandru
utue.personen.roh	Garofano, Aurelio
utue.personen.roh	Koch, Sven Dominik
utue.personen.roh	Fotin-Mleczek, Mariola
utue.personen.roh	Hoerr, Ingmar
utue.personen.roh	Clemens, Ralf
utue.personen.roh	von Sonnenburg, Frank
dcterms.isPartOf.ZSTitelID	Lancet	de_DE
dcterms.isPartOf.ZS-Issue	10101	de_DE
dcterms.isPartOf.ZS-Volume	390	de_DE
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät
utue.fakultaet	Sonstige